• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Alpha Cognition Inc. - Common Stock (NQ:ACOG)

    8.580 UNCHANGED
    Delayed Quote Updated: 4:00 PM EDT, Oct 21, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 8.580
    Bid (Size) 3.460 (100)
    Ask (Size) 12.00 (100)
    Prev. Close 8.580
    Today's Range 8.580 - 8.580
    52wk Range 4.500 - 10.14
    Shares Outstanding 146,925,149
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Alpha Cognition Announces Publication of U.S. Patent Application Relating to Proprietary Manufacturing Process for ZUNVEYL®
    From Alpha Cognition Inc.
    Via Business Wire
    News headline image
    Alpha Cognition to Present New ZUNVEYL® (Benzgalantamine) Clinical and Real-World Data at ASCP Annual Meeting and NEI Fall Congress
    From Alpha Cognition Inc.
    Via Business Wire

    Performance

    52-Week Range 15.4% below 52-week high
    8.580
    4.5052W Low 10.1452W High
    1 Week 4.0% below 1-week high
    8.051W Low 8.941W High

    Alpha Cognition Inc. - Common Stock (ACOG) traded between $4.50 and $10.14 over the past 52 weeks and last traded at $8.58, 15.4% below its 52-week high. Over the past week it ranged between $8.05 and $8.94.

    Past 12 Months
    +1.5%
    -4.3%
    +8.6%
    +22.7%
    +32.0%
    +25.3%
    1W +$0.13
    1M -$0.39
    3M +$0.68
    6M +$1.59
    YTD +$2.08
    1Y +$1.73

    ACOG was +25.3% over the past year, +22.7% over six months, +32.0% year to date, +1.5% in the last week.

    12 Months vs Market
    ACOG
    +25.3%
    DIA
    +12.5%
    SPY
    +15.2%
    QQQ
    +18.6%
    IWM
    +11.9%

    Over the past 12 months ACOG returned +25.3% versus DIA (Dow) +12.5%, SPY (S&P 500) +15.2%, QQQ (Nasdaq 100) +18.6% and IWM (Russell 2000) +11.9%.

    Volume & Liquidity
    1W
    112.9K
    1M
    95.7K
    3M
    125.5K
    6M
    87.2K
    YTD
    80.2K
    1Y
    84.7K

    ACOG's 3-month average daily volume is 125.5K.

    More News

    Read More
    News headline image
    Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Alpha Cognition Inc.
    Via Business Wire
    News headline image
    Alpha Cognition Announces CONVERGE Real-World Evidence on ZUNVEYL®(Benzgalantamine) Use in Long-Term Care
    From Alpha Cognition Inc.
    Via Business Wire
    Alpha Cognition (NASDAQ:ACOG) Q1 Revenue Meets Estimates as Commercial Momentum Builds ↗
    Via Chartmill
    News headline image
    Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Alpha Cognition Inc.
    Via Business Wire
    News headline image
    Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Alpha Cognition Inc.
    Via Business Wire
    News headline image
    Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26
    Via Newsfile
    News headline image
    Alpha Cognition (ACOG) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Alpha Cognition Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Alpha Cognition Q2 2026 Earnings Call Transcript ↗
    Via Benzinga
    Topics Earnings
    News headline image
    Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update
    From Alpha Cognition Inc.
    Via Business Wire
    News headline image
    Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update
    From Alpha Cognition Inc.
    Via Business Wire
    News headline image
    Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease
    From Alpha Cognition Inc.
    Via Business Wire
    News headline image
    Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit
    From Alpha Cognition Inc.
    Via Business Wire
    News headline image
    Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board
    From Alpha Cognition Inc.
    Via Business Wire
    News headline image
    Alpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer’s Disease
    From Alpha Cognition, Inc.
    Via Business Wire
    News headline image
    Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease
    From Alpha Cognition Inc.
    Via Business Wire
    News headline image
    Alpha Cognition Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    Alpha Cognition (ACOG) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update
    From Alpha Cognition Inc.
    Via Business Wire
    News headline image
    Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026
    From Alpha Cognition Inc.
    Via Business Wire
    News headline image
    Alpha Cognition Inc. to Participate in Three Upcoming Investor Conferences
    From Alpha Cognition, Inc.
    Via Business Wire
    News headline image
    Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig
    From Alpha Cognition Inc.
    Via Business Wire
    News headline image
    Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Alpha Cognition Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Alpha Cognition Inc. - Common Stock publicly traded?
    Yes, Alpha Cognition Inc. - Common Stock is publicly traded.
    What exchange does Alpha Cognition Inc. - Common Stock trade on?
    Alpha Cognition Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Alpha Cognition Inc. - Common Stock?
    The ticker symbol for Alpha Cognition Inc. - Common Stock is ACOG on the Nasdaq Stock Market
    What is the current price of Alpha Cognition Inc. - Common Stock?
    The current price of Alpha Cognition Inc. - Common Stock is 8.580
    When was Alpha Cognition Inc. - Common Stock last traded?
    The last trade of Alpha Cognition Inc. - Common Stock was at 10/21/26 04:00 PM ET
    What is the market capitalization of Alpha Cognition Inc. - Common Stock?
    The market capitalization of Alpha Cognition Inc. - Common Stock is 1.26B
    How many shares of Alpha Cognition Inc. - Common Stock are outstanding?
    Alpha Cognition Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.